PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.

Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound

Eli Lilly’s blockbuster drug tirzepatide, sold as Mounjaro for type 2 diabetes, has been cleared to treat obesity, making it the second in a highly

November 8, 2023

Landmark Bio, Galapagos sign deal for CAR-T cell therapy

Landmark Bio will manufacture clinical trial batches of Galapagos’ CAR-T cell therapies for haematology-oncology. Credit: Kateryna Kon / Shutterstock.com. Landmark Bio and Galapagos have signed

November 7, 2023

Optimi Health Announces Non-Brokered Private Placement | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – August 7, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-approved, Health

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.